2.5 hours of patient/therapist contact time increases CPAP use

October 22, 2012, American College of Chest Physicians

Although continuous positive airway pressure (CPAP) is often used as therapy for obstructive sleep apnea (OSA), patient compliance with CPAP remains an issue.

However, new research presented at CHEST 2012, the annual meeting of the , shows that patients who meet with a respiratory therapist for a total of 2.5 hours within 30 days of initiating CPAP had significant compliance after 1 month of therapy.

Researchers from Kaiser Permanente retrospectively reviewed the charts of 39 patients with OSA who were treated with CPAP and on a portable compliance-monitoring device.

Patient/therapist contact time included a total of three sessions, each with one-on-one contact time, totaling 150 min. On day 30, a 30-min CPAP compliance evaluation review was conducted, and data was downloaded from patients' CPAP equipment.

Results showed a 75% CPAP compliance rate after 30 days.

Explore further: CPAP found to improve sexual function, satisfaction in men with sleep apnea

Related Stories

CPAP found to improve sexual function, satisfaction in men with sleep apnea

June 13, 2012
Men who suffer from obstructive sleep apnea (OSA) are seeing another potential benefit from continuous positive airway pressure therapy, or CPAP: improved sexual function and satisfaction in non-diabetic men under age 60.

Two-week course of sleep aid increases CPAP adherence in OSA patients at six months

May 18, 2009
New research suggests that patients newly diagnosed with obstructive sleep apnea (OSA) who use a short-course of the sleep aid, eszopiclone, when beginning continuous positive airway pressure (CPAP) therapy, are more adherent ...

Benefits from upper airway surgery for sleep apnea found to equal CPAP

August 1, 2009
Adults who struggle with CPAP treatment for obstructive sleep apnea (OSA) should be considered candidates for reconstructive surgery on the upper airway, because it holds the same quality-of-life (QOL) benefits but with more ...

CPAP treatment effective in patients with milder obstructive sleep apnea and daytime sleepiness

July 20, 2012
Continuous positive airway pressure (CPAP), well established as an effective treatment for severe obstructive sleep apnea (OSA), is also effective in patients with mild and moderately severe OSA and daytime sleepiness, according ...

Procedure helps to eliminate sleep apnea

October 24, 2007
A procedure known as uvulopalatopharyngoplasty (UPPP) may help some patients improve or even eliminate their obstructive sleep apnea (OSA), according to a new study. The research, presented at CHEST 2007, the 73rd annual ...

CPAP use reduces incidence of cardiovascular events and hypertension in OSA patients

May 19, 2010
In non-sleepy patients with obstructive sleep apnea (OSA), treatment with continuous positive airway pressure (CPAP) can reduce the incidence of cardiovascular events and hypertension, according to researchers from Spain.

Recommended for you

Sleep apnea, congenital heart disease may be deadly mix for hospitalized infants

September 17, 2018
Infants often aren't screened for sleep apnea, but a new study suggests the disorder may be tied to an increased risk of death in infants with congenital heart disease.

Sleep deficiency increases risk of a motor vehicle crash

April 4, 2018
Excessive sleepiness can cause cognitive impairments and put individuals at a higher risk of motor vehicle crash. However, the perception of impairment from excessive sleepiness quickly plateaus in individuals who are chronically ...

Sleep apnea study finds male-female differences in cerebral cortex thickness, symptoms

March 13, 2018
Researchers from the UCLA School of Nursing examined clinical records and magnetic resonance imaging brain scans of patients who were recently diagnosed with sleep apnea, and discovered several apparent connections between ...

Synthetic cannabinoid reduces sleep apnea

November 29, 2017
A synthetic version of a molecule found in the cannabis plant was safe and effective in treating obstructive sleep apnea in the first large, multi-site study of a drug for the sleep disorder funded by the National Institutes ...

Sleeping through the snoring: Researchers identify neurons that rouse the brain to breathe

November 2, 2017
A common and potentially serious sleep disorder, obstructive sleep apnea affects at least one quarter of U.S. adults and is linked to increased risk of diabetes, obesity and cardiovascular disease. In a paper published today ...

Remede system approved for sleep apnea

October 9, 2017
(HealthDay)—The Remede sleep system, an implanted device that treats central sleep apnea by activating a nerve that sends signals to the diaphragm to stimulate breathing, has been approved by the U.S. Food and Drug Administration.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.